UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): December 30, 2019
STRATA SKIN SCIENCES, INC.
(Exact Name of Registrant Specified in Charter)
|
Delaware
|
000-51481
|
13-3986004
|
|
(State or Other Jurisdiction
|
(Commission File Number)
|
(I.R.S. Employer
|
|
of Incorporation)
|
|
Identification No.)
|
|
|
|
|
|
|
5 Walnut Grove Drive, Suite 140, Horsham, Pennsylvania
|
19044
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Registrant's telephone number, including area code: 215-619-3200
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
□ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
□ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
□ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
□ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading
Symbol(s) |
Name of each exchange on which registered
|
|
Common Stock, $0.001 par value per share
|
SSKN
|
The NASDAQ Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company □
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □
| ITEM 5.07 |
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
On December 30, 2019, STRATA Skin Sciences, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The matters voted
upon were:
(1) the election of seven director nominees to the Company’s board of directors to serve until the next annual meeting of the Company’s stockholders
or until their successors are elected and qualify, subject to their prior death, resignation or removal; and
(2) to ratify the selection by the Audit Committee of the Board of Directors of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.
The results of the voting for each proposal were as follows:
(1) Each of the director nominees to the Company’s board of directors was elected:
|
Nominees
|
Votes For
|
Votes Withheld
|
Broker
Non-Vote
|
|||
|
Dr. Uri Geiger
|
20,533,997
|
11,492
|
4,778,020
|
|||
|
David N. Gill
|
19,876,816
|
668,673
|
4,778,020
|
|||
|
Samuel Navarro
|
20,527,066
|
18,423
|
4,778,020
|
|||
|
Dr. Dolev Rafaeli
|
20,477,211
|
68,278
|
4,778,020
|
|||
|
Samuel Rubinstein
|
20,530,033
|
15,456
|
4,778,020
|
|||
|
Nachum Shamir
|
20,532,054
|
13,435
|
4,778,020
|
|||
|
LuAnn Via
|
20,522,940
|
22,999
|
4,778,020
|
|||
(2) To ratify the selection by the Audit Committee of the Board of Directors of
Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019, was approved:
|
Votes For
|
Votes Against
|
Abstain
|
||
|
24,832,293
|
23,605
|
467,611
|
||
- 2 -
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
|
STRATA SKIN SCIENCES, INC.
|
|
|
|
|
|
|
|
|
Date: December 30, 2019
|
By:
|
/s/ Matthew C. Hill
|
|
|
|
|
Matthew C. Hill
|
|
|
|
|
Chief Financial Officer
|
|